Concepedia

Publication | Open Access

Phase I/II study of tirabrutinib, a second-generation Bruton’s tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma

DOIFull Paper Access

170

Citations

32

References

2020

Year

Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, Yasuhito Terui, Yoshiki Arakawa, Hajime Yonezawa, Katsunori Asai, Noriko Fukuhara, Kazuhiko Sugiyama, Naoki Shinojima,
Neuro-Oncology

Abstract

JapicCTI-173646.

References

YearCitations

Page 1